With more and more people signing up for weight loss drugs, the potential side effects are starting to attract attention.

Novo Nordisk A/S Data across obesity, cardiovascular disease, MASH, type 2 diabetes, as well as advances in obesity-related ...

The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known ...

The FDA will decide whether to approve a once-daily, 25 mg oral formulation of semaglutide (Wegovy) by the end of 2025. If ...

As weight-loss injectables like Ozempic skyrocket in popularity, a new offshoot trend is starting to take hold: microdosing.

The reserarchers found that a weekly dose of semaglutide was effective at treating Metabolic Dysfunction-Associated ...